2. Signaling Pathways
  3. Protein Tyrosine Kinase/RTK
  4. PDGFR
  5. PDGFR Isoform
  6. PDGFR Antagonist

PDGFR Antagonist

PDGFR Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-148514
    CT52923
    		Antagonist 98.58%
    CT52923 is a selective, orally active platelet-derived growth factor receptor (PDGFR) antagonist. CT52923 also is an ATP-competitive inhibitor. CT52923 can be used for the research variety of pathological diseases, including atherosclerosis, glomerulonephritis, liver cirrhosis, pulmonary fibrosis, and cancer.